This page is not the official website. Generated by AI, does not constitute any advice. If needed, please click here to visit the corresponding official website.

One-Stop CRDMO Service Provider for Innovative Pharmaceutical Solutions

Lianhe Aigen delivers cutting-edge chemistry-driven innovation across drug discovery, process development, contract manufacturing, and full CMC compliance — accelerating your path from concept to commercialization.

Explore Services Contact Us

1500+

Employees

200+

Scientists

25+

Years of Experience

About Lianhe Aigen

Lianhe Aigen Pharma Co., Ltd. is a leading provider of innovative drug solutions at home and abroad. Our Shanghai R&D center, Lianhe Aigen Pharmatech Co., Ltd., operates as a CRO platform delivering preclinical new drug discovery services to global clients. Our Taizhou site, formerly known as Lianhe Chemical Technology (Taizhou) Co., Ltd., functions as a fully integrated CDMO platform supporting end-to-end pharmaceutical development and manufacturing.

With a proven track record of compliance and quality, our facilities have been inspected and approved by six key global health authorities including NMPA, FDA, EMA, PMDA, TGA, and KFDA — ensuring reliable, on-time, high-quality delivery for our partners worldwide.

Learn More
Lianhe Aigen Facility

Our Core Services

We offer comprehensive, integrated CRDMO services designed to support pharmaceutical innovation from early discovery through commercial supply.

Drug Discovery

Full-range chemistry services covering all phases of drug discovery, delivering high-quality compounds from milligrams to kilograms.

Process Development

QbD-driven process development with expertise in handling complex and hazardous chemicals to deliver robust, efficient, and green synthetic routes.

Contract Manufacturing

GMP-compliant manufacturing with facilities approved by FDA, EMA, NMPA, and other global regulators for clinical and commercial supply.

CMC Service

End-to-end CMC solutions including route scouting, impurity control, method development, stability studies, and global regulatory submissions.

Technology Platforms

Our advanced technology platforms integrate innovation, engineering, and analytical excellence to solve complex challenges in pharmaceutical development.

R&D Technology Innovation

Technology-driven innovation combining synthesis, analysis, and engineering to deliver novel solutions.

Production Technology

Green chemistry principles with flow chemistry, enzyme catalysis, electrochemistry, and photochemistry in commercial production.

Analytical Platform

Integrated quality control services including method development, validation, impurity analysis, and stability studies.

Flow Chemistry

Continuous flow processing for safer, scalable, and more efficient synthesis of complex molecules.

Solid State Chemistry

Polymorph screening, salt selection, and solid-form optimization for improved drug performance.

Amino Acid & Peptide

Expertise in peptide synthesis, purification, and characterization for therapeutic development.

ADC/PROTAC Linker

Design and synthesis of advanced linkers for targeted protein degradation and antibody-drug conjugates.

Oligonucleotide Platform

Full-service support for oligonucleotide synthesis, modification, and analytical characterization.

Featured Products & Intermediates

Our portfolio includes a wide range of high-purity chemical compounds, APIs, and intermediates developed through advanced synthetic technologies.

Peptide Intermediate

Custom Peptide Intermediate

High-purity peptide building blocks for therapeutic development.

Peptide
ADC Linker

ADC Linker Compound

Stable, cleavable linkers for antibody-drug conjugate applications.

ADC
Oligonucleotide

Modified Oligonucleotide

Phosphorothioate and 2'-O-methyl modified sequences.

Oligonucleotide
Heterocyclic Compound

Heterocyclic API Intermediate

Complex nitrogen-containing scaffolds for kinase inhibitors.

API Intermediate
Chiral Molecule

Enantiopure Chiral Compound

Asymmetric synthesis with >99% ee for CNS and metabolic targets.

Chiral
PROTAC Molecule

PROTAC Degrader Intermediate

Bifunctional molecules for targeted protein degradation.

PROTAC
Amino Acid Derivative

Non-Natural Amino Acid

Beta- and gamma-amino acids for peptide engineering.

Amino Acid
Flow Chemistry Product

Continuous Flow Synthesis Product

Scalable, safe production of high-energy intermediates.

Flow Chemistry

Contact Lianhe Aigen

For business inquiries, product information, or partnership opportunities, please reach out through our official channels.

Headquarters

Lianhe Aigen Pharma Co., Ltd.

No.3 Donghai 8th Avenue, Toumengang New District, Linhai, Taizhou City, Zhejiang Province, China, P.C.317016

Tel: +86 576 8558 1608

Email: [email protected]

Business: [email protected], [email protected]

Careers: [email protected]

Visit Official Website
China Quality Suppliers fobcompany.info

Notice for Buyers: If you are a buyer, the above information is generated by AI collection and does not constitute any advice. If necessary, please visit the corresponding official website.

For Domain Owners: If you are the domain owner and do not want to be included by fobcompany.info, please contact [email protected] via your corporate email to cancel. We will cancel your inclusion within 3 business days.

如果您是域名所有者 不想被fobcompany.info收录 请用企业邮箱联系[email protected] 取消收录 我们将在3个工作日取消您的收录

Service Request: If you are other domain and want to be included, please contact [email protected]

如果您是其他域名合作 也请联系[email protected]